Schedule 13G ownership disclosure

APYX MEDICAL CORPORATION

Common Stock · CUSIP: 03837C106

Event date: 2025-12-31

Filing-level shares
2,443,035.00
Percent of class
5.95%
  • ROYCE & ASSOCIATES LP

    Shares: 2,443,035.00 · Class: 5.95%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000906304-26-000004
Form type
SCHEDULE 13G/A
Filer
Apyx Medical Corp
CIK
CIK 719135
Filed
Jan 20, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub